FDA Inspection 1020255 — Christus Spohn Hospital Corpus Christi
The FDA completed an inspection of Christus Spohn Hospital Corpus Christi on Jul 10, 2017 in Corpus Christi, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 10, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Corpus Christi, TX (United States)